| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.24 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |